Analyst Ratings February 5, 2026

Truist Keeps Buy Rating on Amcor, $60 Price Target After Q2 Results

EPS outpaces expectations while revenue lags; synergies and divestiture plans remain focal points

By Ajmal Hussain AMCR
Truist Keeps Buy Rating on Amcor, $60 Price Target After Q2 Results
AMCR

Truist Securities maintained its Buy rating and $60.00 price target on Amcor Plc. following the company's Q2 2026 results. Adjusted operating EPS of $0.86 beat both Truist's $0.79 estimate and the Street consensus of $0.84, while revenue of $5.4 billion missed an expected $5.52 billion. Amcor reported progress on integration synergies and is advancing alternatives for about $2.5 billion of non-core assets, with continued focus on the North America beverage unit and further synergy delivery in the coming quarter.

Key Points

  • Truist Securities reiterated a Buy rating on Amcor and maintained a $60.00 price target following Q2 2026 results.
  • Adjusted operating EPS was $0.86, beating Truist's $0.79 estimate and the Street consensus of $0.84, while revenue of $5.4 billion missed the $5.52 billion projection.
  • Amcor delivered $55 million in synergies (top end of guidance), reported more than $100 million in annualized revenue synergies post-Berry integration, and is pursuing alternatives for about $2.5 billion of non-core assets including its North America beverage segment.

Overview

Truist Securities has reiterated a Buy rating on Amcor Plc and left its price target at $60.00 after the packaging company released its Q2 2026 results. The company's adjusted operating earnings per share for the quarter came in at $0.86, topping Truist's internal forecast of $0.79 and the broader Street consensus of $0.84.

Earnings and top-line performance

While Amcor's adjusted EPS slightly exceeded expectations, revenue for the quarter was $5.4 billion, below the projected $5.52 billion. The company nevertheless saw its shares hold up in aftermarket trading despite the revenue shortfall.

Volumes and core portfolio

Amcor reported that volumes across its core portfolio - which includes healthcare, beauty and wellness, pet food, foodservice, liquids, and protein categories - declined by roughly 1.5% during the quarter. That rate of decline was comparable to the prior quarter, indicating a continuation rather than a meaningful acceleration of volume trends across these end markets.

Synergy delivery and integration progress

The company achieved $55 million in synergies in the period, hitting the top end of its guidance range of $50-55 million. Amcor said those savings were primarily realized through G&A headcount reductions and procurement efficiencies, and included $5 million attributable to financial benefits. Management also reported revenue synergies have reached in excess of $100 million in annualized sales to date - an increase of more than $30 million compared with the prior quarter - as the company optimizes spending and specifications across its combined supplier base following the Berry integration.

Portfolio simplification and next-quarter outlook

Amcor continues to explore strategic alternatives for approximately $2.5 billion of non-core businesses, and noted constructive conversations specifically regarding its North America beverage segment. Looking ahead, the company expects to deliver between $70 million and $80 million in synergies in the next quarter.

Analyst reaction and peer commentary

Alongside Truist's reiteration of the Buy rating and $60 price target, Baird raised its price objective on Amcor to $54.00 from $50.00 and kept an Outperform rating in place. Baird cited expectations for a multi-year period of low double-digit earnings growth driven by synergies from the Berry Global acquisition.

Bottom line

The quarter was characterized by an earnings beat against expectations, a revenue miss, steady but slightly negative volume trends in core categories, and clearer progress on integration-related synergy delivery. Management's continued work to monetize non-core assets and the projected uplift in next-quarter synergies are central to forecasts and analyst positioning.


Note - This article reports the company's disclosed figures and the named analyst actions without extrapolating beyond the information provided by the company and the analysts.

Risks

  • Revenue shortfall versus expectations could pressure investor sentiment and valuations in the packaging and industrial sectors.
  • Ongoing declines in core portfolio volumes (about -1.5%) pose uncertainty for near-term top-line recovery in end markets such as healthcare, foodservice and consumer goods.
  • The process to divest or otherwise dispose of roughly $2.5 billion in non-core businesses, including the North America beverage unit, introduces execution and timing risk that could affect financial outcomes for the industrial and packaging sectors.

More from Analyst Ratings

Stifel Lowers JFrog Target Citing AI-Driven Security Concerns; Maintains Buy Rating Feb 22, 2026 HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026